.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Harvard Business School
Chinese Patent Office
US Army
Cantor Fitzgerald
Cipla
Daiichi Sankyo
Citi
Novartis
Argus Health

Generated: December 17, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: morphine sulfate; naltrexone hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321NDASTAT RX USA LLC16590-897-3030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16590-897-30)
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321NDASTAT RX USA LLC16590-897-9090 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16590-897-90)
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321NDASTAT RX USA LLC16590-897-6060 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16590-897-60)
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321NDAPfizer Laboratories Div Pfizer Inc60793-430-2030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60793-430-20)
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321NDAPfizer Laboratories Div Pfizer Inc60793-431-2030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60793-431-20)
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321NDAPfizer Laboratories Div Pfizer Inc60793-433-2030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60793-433-20)
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321NDAPfizer Laboratories Div Pfizer Inc60793-434-2030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60793-434-20)
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321NDAPfizer Laboratories Div Pfizer Inc60793-435-2030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60793-435-20)
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321NDAPfizer Laboratories Div Pfizer Inc60793-437-2030 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60793-437-20)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Express Scripts
Johnson and Johnson
Chubb
Deloitte
Teva
Daiichi Sankyo
UBS
Novartis
Dow

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot